Compare Stocks: EVO, MRVI, FTRE, and BLFS

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLFS BioLife Solutions	$38.61	$36.36	$17.86 ▼ $39.76	$1.89B	1.82	1.18 million shs	N/A
EVO Evotec	$1.53 -2.5%	$1.80	$1.50 ▼ $4.27	$544.40M	1.97	189,260 shs	40,005 shs
FTRE Fortrea	$20.84 +2.3%	$18.88	$8.55 ▼ $23.51	$1.98B	1.93	1.75 million shs	931,160 shs
MRVI Maravai LifeSciences	$7.44 +3.2%	$7.18	$2.55 ▼ $9.42	$1.93B	0.54	2.69 million shs	2.30 million shs

7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLFS BioLife Solutions	0.00%	+3.51%	+10.57%	+37.01%	+41.22%
EVO Evotec	0.00%	-4.38%	-13.56%	-45.16%	-61.56%
FTRE Fortrea	0.00%	+4.20%	+22.44%	+17.34%	+105.73%
MRVI Maravai LifeSciences	0.00%	-5.82%	+10.55%	+22.17%	+123.42%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLFS BioLife Solutions	$38.61	$36.36	$17.86 ▼ $39.76	$1.89B	1.82	1.18 million shs	N/A
EVO Evotec	$1.53 -2.5%	$1.80	$1.50 ▼ $4.27	$544.40M	1.97	189,260 shs	40,005 shs
FTRE Fortrea	$20.84 +2.3%	$18.88	$8.55 ▼ $23.51	$1.98B	1.93	1.75 million shs	931,160 shs
MRVI Maravai LifeSciences	$7.44 +3.2%	$7.18	$2.55 ▼ $9.42	$1.93B	0.54	2.69 million shs	2.30 million shs

7 Stocks That Will Be Magnificent in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLFS BioLife Solutions	0.00%	+3.51%	+10.57%	+37.01%	+41.22%
EVO Evotec	0.00%	-4.38%	-13.56%	-45.16%	-61.56%
FTRE Fortrea	0.00%	+4.20%	+22.44%	+17.34%	+105.73%
MRVI Maravai LifeSciences	0.00%	-5.82%	+10.55%	+22.17%	+123.42%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BLFS BioLife Solutions	2.09	Hold	$31.38	-18.74% Downside
EVO Evotec	2.00	Hold	$3.00	96.08% Upside
FTRE Fortrea	2.42	Hold	$22.10	6.05% Upside
MRVI Maravai LifeSciences	2.60	Moderate Buy	$7.38	-0.87% Downside

Current Analyst Ratings Breakdown

Latest EVO, MRVI, FTRE, and BLFS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/6/2026	FTRE Fortrea	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$22.00 ➝ $23.00
10/5/2026	MRVI Maravai LifeSciences	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$9.00
10/5/2026	MRVI Maravai LifeSciences	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong-Buy
9/30/2026	FTRE Fortrea	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$22.00
9/30/2026	FTRE Fortrea	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
9/22/2026	BLFS BioLife Solutions	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D-) ➝ Hold (C)
9/21/2026	BLFS BioLife Solutions	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
9/9/2026	MRVI Maravai LifeSciences	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$2.50 ➝ $8.00
9/9/2026	MRVI Maravai LifeSciences	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral ➝ Hold	$2.50 ➝ $8.00
8/26/2026	MRVI Maravai LifeSciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
8/25/2026	EVO Evotec	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)

(Data available from 10/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BLFS BioLife Solutions	$106.69M	17.71	$0.23 per share	168.62	$7.72 per share	5.00
EVO Evotec	$891.97M	0.61	N/A	N/A	$2.59 per share	0.59
FTRE Fortrea	$2.72B	0.73	$9.92 per share	2.10	$6.10 per share	3.42
MRVI Maravai LifeSciences	$185.74M	10.40	$0.42 per share	17.77	$1.46 per share	5.10

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BLFS BioLife Solutions	-$4.59M	$1.16	33.28	241.31	N/A	53.29%	2.70%	2.49%	11/5/2026 (Estimated)
EVO Evotec	-$117.12M	N/A	N/A	38.25	N/A	-26.20%	-24.93%	-11.35%	11/5/2026 (Estimated)
FTRE Fortrea	-$986.20M	-$0.91	N/A	19.66	0.50	-3.18%	10.72%	2.17%	10/29/2026 (Estimated)
MRVI Maravai LifeSciences	-$130.77M	-$0.52	N/A	N/A	N/A	-37.07%	-15.70%	-8.17%	11/5/2026 (Estimated)

Latest EVO, MRVI, FTRE, and BLFS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/5/2026	Q3 2026	BLFS BioLife Solutions	$0.05	N/A	N/A	N/A	$29.13 million	N/A
11/5/2026	Q3 2026	EVO Evotec	-$0.3087	N/A	N/A	N/A	$167.20 million	N/A
11/5/2026	Q3 2026	MRVI Maravai LifeSciences	-$0.0563	N/A	N/A	N/A	$43.56 million	N/A
10/29/2026	Q3 2026	FTRE Fortrea	$0.2163	N/A	N/A	N/A	$671.57 million	N/A
8/6/2026	Q2 2026	BLFS BioLife Solutions	$0.0313	$0.91	+$0.8788	$0.91	$27.80 million	$28.47 million
8/6/2026	Q2 2026	MRVI Maravai LifeSciences	-$0.0435	-$0.02	+$0.0235	-$0.08	$48.67 million	$51.44 million
7/29/2026	Q2 2026	FTRE Fortrea	$0.1804	$0.23	+$0.0496	-$0.14	$647.57 million	$678.20 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BLFS BioLife Solutions	N/A	N/A	N/A	N/A	N/A
EVO Evotec	N/A	N/A	N/A	N/A	N/A
FTRE Fortrea	N/A	N/A	N/A	N/A	N/A
MRVI Maravai LifeSciences	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BLFS BioLife Solutions	N/A	9.69	7.14
EVO Evotec	0.62	2.33	2.21
FTRE Fortrea	1.98	0.96	0.96
MRVI Maravai LifeSciences	0.49	4.05	2.98

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BLFS BioLife Solutions	93.24%
EVO Evotec	5.81%
FTRE Fortrea	N/A
MRVI Maravai LifeSciences	50.25%

Insider Ownership

Company	Insider Ownership
BLFS BioLife Solutions	2.20%
EVO Evotec	N/A
FTRE Fortrea	0.73%
MRVI Maravai LifeSciences	2.49%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BLFS BioLife Solutions	155	48.92 million	47.85 million	Optionable
EVO Evotec	4,553	355.82 million	N/A	Not Optionable
FTRE Fortrea	14,300	95.10 million	94.41 million	Optionable
MRVI Maravai LifeSciences	415	259.67 million	253.21 million	Optionable

EVO, MRVI, FTRE, and BLFS Headlines

Recent News About These Companies

Millennium reported a 5.20 percent stake while Maravai LifeSciences stock traded at EUR 6.58

October 8 at 6:02 PM | ad-hoc-news.deA

Maravai LifeSciences (NASDAQ:MRVI) Stock Moved Up to "Strong-Buy" by TD Cowen

October 6, 2026 | americanbankingnews.com

Maravai LifeSciences (NASDAQ:MRVI) Stock Rating Upgraded by TD Cowen

October 6, 2026 | marketbeat.com

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stock Now Rated "Hold" by Wall Street Analysts

October 5, 2026 | americanbankingnews.com

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stock Has Average Price Target of $6.83

October 5, 2026 | marketbeat.com

Comparing Bullfrog AI (NASDAQ:BFRG) & Maravai LifeSciences (NASDAQ:MRVI)

October 5, 2026 | americanbankingnews.com

What Is Maravai’s (MRVI) Comeback Really Worth to Investors?

October 4, 2026 | insidermonkey.com

Maravai's TriLink Gets New China Patent for CleanCap Technology

September 29, 2026 | marketscreener.comM

TriLink BioTechnologies® Secures Additional China Patent for CleanCap® Technology, Adding Broad Composition-of-Matter Protection to Reinforce Its Global IP

September 29, 2026 | businesswire.com

Maravai LifeSciences stock gets a USD 8.00 UBS target

September 28, 2026 | ad-hoc-news.deA

Maravai LifeSciences Holdings, Inc. Class A Common Stock

September 25, 2026 | fxempire.comF

Maravai LifeSciences Holdings (MRVI) Rebounded Sharply, Is The Upside Already Priced In?

September 24, 2026 | finance.yahoo.com

Maravai LifeSciences stock gains 3.74 percent as market value reaches USD 326.82 million

September 22, 2026 | ad-hoc-news.deA

Maravai LifeSciences stock falls after recent slide, investors eye latest results

September 20, 2026 | ad-hoc-news.deA

Maravai LifeSciences (NASDAQ:MRVI) Stock Price Down 5.7% - Here's Why

September 18, 2026 | marketbeat.com

Analysts Are Bullish on These Healthcare Stocks: Maravai Lifesciences Holdings (MRVI), Thermo Fisher (TMO)

September 18, 2026 | theglobeandmail.com

Maravai LifeSciences (NASDAQ:MRVI) Upgraded at UBS Group

September 12, 2026 | marketbeat.com

Maravai LifeSciences: The Post-COVID Reset Has Created An RNA Consumables Flywheel

September 2, 2026 | seekingalpha.com

TEM, BNTX, MRVI, RGEN, NVAX stock rallies as Moderna-Merck cancer vaccine clears late-stage trial

August 19, 2026 | msn.com

Stifel Nicolaus Sticks to Their Buy Rating for Maravai Lifesciences Holdings (MRVI)

August 15, 2026 | theglobeandmail.com

Maravai LifeSciences (MRVI) Releases Q2 2026 Earnings: Revenue Beats Estimates and Loss Narrows

August 7, 2026 | quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

EVO, MRVI, FTRE, and BLFS Company Descriptions

BioLife Solutions NASDAQ:BLFS

$38.61 0.00 (0.00%)

As of 10/9/2026

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Evotec NASDAQ:EVO

$1.53 -0.04 (-2.55%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$1.53 0.00 (0.00%)

As of 10/9/2026 07:30 PM Eastern

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health. It has collaboration agreements with SK bioscience, JingXin, Carrick Therapeutics, Sernova, Topas Therapeutics, Exscientia, CONBA Group, Centrexion, Sanofi/NIH, Kazia Therapeutics, Bristol Myers Squibb, Topas Therapeutics, Immunitas, Exscientia, and Bayer; and Inserm, the French National Institute of Health and Medical Research, Lille University Hospital, and Inserm Transfert to identify novel therapeutic targets and diagnostic and prognostic markers in obesity and metabolic diseases, as well as collaboration with CHDI Foundation, Inc.; and a strategic partnership with Dewpoint Therapeutics to advance its portfolio targeting biomolecular condensates as a novel domain for therapeutic intervention towards the clinic, as well as research collaboration with Pfizer for metabolic and infectious diseases. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Fortrea NASDAQ:FTRE

$20.84 +0.47 (+2.31%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$21.28 +0.44 (+2.11%)

As of 10/9/2026 07:30 PM Eastern

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Maravai LifeSciences NASDAQ:MRVI

$7.44 +0.23 (+3.19%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$7.45 +0.01 (+0.13%)

As of 10/9/2026 07:57 PM Eastern

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest EVO, MRVI, FTRE, and BLFS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest EVO, MRVI, FTRE, and BLFS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

EVO, MRVI, FTRE, and BLFS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

EVO, MRVI, FTRE, and BLFS Company Descriptions

BioLife Solutions NASDAQ:BLFS

Evotec NASDAQ:EVO

Fortrea NASDAQ:FTRE

Maravai LifeSciences NASDAQ:MRVI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest EVO, MRVI, FTRE, and BLFS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest EVO, MRVI, FTRE, and BLFS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

EVO, MRVI, FTRE, and BLFS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

EVO, MRVI, FTRE, and BLFS Company Descriptions

BioLife Solutions NASDAQ:BLFS

Evotec NASDAQ:EVO

Fortrea NASDAQ:FTRE

Maravai LifeSciences NASDAQ:MRVI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools